Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Altman

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|August 19, 2024
Table Stakes for Equity - Consumer Demographic Data at a State-Based MarketplaceS Monica Soni, Jessica Altman
American Journal of Hematology|August 20, 2010
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?Ritesh Parajuli, Jessica Altman, Timothy Kuzel, et al.
Echocardiography (Mount Kisco, N.Y.)|May 28, 2026
A Comprehensive Echocardiographic Assessment of Patients With Chronic Myeloid Leukemia on DasatinibChen Chen, Vinesh Appadurai, Maria Paulina Hernandez, et al.
Leukemia Research|June 14, 2013
Dose-intense etoposide-cyclophosphamide without stem cell transplantation for patients with intermediate and high cytogenetic risk primary refractory and relapsed acute myeloid leukemiaSteven Trifilio, Zheng Zhou, Jessica Altman, et al.
Leukemia Research|June 4, 2013
Idarubicin appears equivalent to dose-intense daunorubicin for remission induction in patients with acute myeloid leukemiaSteven Trifilio, Zheng Zhou, Jayesh Mehta, et al.
International Journal of Hematology|August 26, 2016
Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopeniaJulie Waisbren, Shira Dinner, Jessica Altman, et al.
Leukemia & Lymphoma|October 10, 2022
Non-leukemic presentation of acute promyelocytic leukemia as a testicular mass with associated non-canonical <i>FLT3</i> mutationBarina Aqil, Juehua Gao, Heidi R Rahn, et al.
Leukemia Research|December 17, 2011
Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemiaSteven M Trifilio, Alfred W Rademaker, Diane Newman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Promoting the Shared-Care Model for Adolescent and Young Adults With Cancer: Optimizing Referrals and Care Coordination With Primary Care ProvidersKaren E Kinahan, Sheetal Kircher, Jessica Altman, et al.
Human Pathology|June 15, 2024
CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemiaAhmed Mohamed, Juehua Gao, Yi-Hua Chen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|August 19, 2024
Table Stakes for Equity - Consumer Demographic Data at a State-Based MarketplaceS Monica Soni, Jessica Altman
American Journal of Hematology|August 20, 2010
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?Ritesh Parajuli, Jessica Altman, Timothy Kuzel, et al.
Echocardiography (Mount Kisco, N.Y.)|May 28, 2026
A Comprehensive Echocardiographic Assessment of Patients With Chronic Myeloid Leukemia on DasatinibChen Chen, Vinesh Appadurai, Maria Paulina Hernandez, et al.
Leukemia Research|June 14, 2013
Dose-intense etoposide-cyclophosphamide without stem cell transplantation for patients with intermediate and high cytogenetic risk primary refractory and relapsed acute myeloid leukemiaSteven Trifilio, Zheng Zhou, Jessica Altman, et al.
Leukemia Research|June 4, 2013
Idarubicin appears equivalent to dose-intense daunorubicin for remission induction in patients with acute myeloid leukemiaSteven Trifilio, Zheng Zhou, Jayesh Mehta, et al.
International Journal of Hematology|August 26, 2016
Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopeniaJulie Waisbren, Shira Dinner, Jessica Altman, et al.
Leukemia & Lymphoma|October 10, 2022
Non-leukemic presentation of acute promyelocytic leukemia as a testicular mass with associated non-canonical <i>FLT3</i> mutationBarina Aqil, Juehua Gao, Heidi R Rahn, et al.
Leukemia Research|December 17, 2011
Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemiaSteven M Trifilio, Alfred W Rademaker, Diane Newman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Promoting the Shared-Care Model for Adolescent and Young Adults With Cancer: Optimizing Referrals and Care Coordination With Primary Care ProvidersKaren E Kinahan, Sheetal Kircher, Jessica Altman, et al.
Human Pathology|June 15, 2024
CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemiaAhmed Mohamed, Juehua Gao, Yi-Hua Chen, et al.
Pageof 3